Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.
Quick Stats
Feb 03, 202653.6
AI Score
HOLD0.67
Volume Ratio
Feb 11, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
GMAB Stock Summary
Last updated Feb 03, 2026
GMAB is currently trading at $33.03, positioned above its 200-day moving average of $26.67, indicating a long-term uptrend. The stock has a 52-week range of $17.235 to $35.43.
Technical Analysis: The 50-day moving average stands at $32.46, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.354, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.264, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates GMAB at 53.6/100 with a HOLD recommendation.
GMAB (Genmab A/S ADS) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.354 |
| CMF (20) | 0.264 |
| ROC (10) | 5.426 |
| ADX (14) | 13.937 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.223 |
| AROONOSC (14) | -14.286 |
| WILLAMS %R (14) | -52.747 |
| MFI (14) | 47.114 |
GMAB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GMAB Price vs Max Options Open Interest
GMAB Max Change In Options Open Interest
GMAB Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GMAB Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GMAB Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GMAB Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Genmab A/S ADS is above both 50 Day and 200 Day SMA which is considered Bullish.
GMAB Moving Averages Analysis
Genmab A/S ADS has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 03, 2026
Genmab A/S ADS has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 03, 2026
GMAB (Genmab A/S ADS) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 33.3 |
| 20 | 33.42 |
| 30 | 33.1 |
| 50 | 32.46 |
| 100 | 31.29 |
| 200 | 26.67 |
GMAB Fundamental Analysis
| P/E (Forward) | 11.7925 |
| P/E (Trailing) | 14.5284 |
| Market Cap ($) | 20.6 billion |
| Earnings/Share ($) | 2.29 |
| Net Proft Margin (%) | 0.4117 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 1.9118 |
| EPS Estimate Next Year ($) | 1.4878 |
| WallStreet Target Price ($) | 38.0714 |
| Most Recent Quarter |